EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-Ad-hoc: CompuGroup Medical SE Co. KGaA / Key word(s): Personnel
CompuGroup Medical SE Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
31-Jul-2024 / 18:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical SE Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
Koblenz, Germany. The general partner of CompuGroup Medical SE Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to terminate his contract prematurely as of August 31, 2024, including resignation from his position as Managing Director and member of the Administrative Board of CompuGroup Medical Management SE as well as of the Joint Committee of the Company.
Effective as of September 1, 2024, the Administrative Board of CompuGroup Medical Management SE appoints Prof. (apl.) Dr. med. Daniel Gotthardt as Managing Director and CEO. Daniel Gotthardt has been Senior Vice President and Chief Medical Officer of the Company since the beginning of 2023. He has also been a member of the Supervisory Board of former CompuGroup Holding AG and CompuGroup Medical SE since 2003, and has been a member of the Administrative Board of CompuGroup Medical Management SE since 2020.
End of Inside Information
31-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
End of Announcement EQS News Service
1958515 31-Jul-2024 CET/CEST